Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Adult Stem Cells Could Hold Key to Creating Cure for Type 1 Diabetes

Published: Tuesday, June 04, 2013
Last Updated: Tuesday, June 04, 2013
Bookmark and Share
Combining bone marrow cells with new drug restores insulin production.

Millions of people with type 1 diabetes depend on daily insulin injections to survive. They would die without the shots because their immune system attacks the very insulin-producing cells it was designed to protect.

Now, a University of Missouri scientist has discovered that this attack causes more damage than scientists realized.

The revelation is leading to a potential cure that combines adult stem cells with a promising new drug.

The discovery is reported in the current online issue of Diabetes, the American Diabetes Association's flagship research publication.

Habib Zaghouani, PhD, J. Lavenia Edwards Chair in Pediatrics, leads the research with his team at the MU School of Medicine.

"We discovered that type 1 diabetes destroys not only insulin-producing cells but also blood vessels that support them," Zaghouani said. "When we realized how important the blood vessels were to insulin production, we developed a cure that combines a drug we created with adult stem cells from bone marrow. The drug stops the immune system attack, and the stem cells generate new blood vessels that help insulin-producing cells to multiply and thrive."

Surrounded by an army of students and a colony of mice, Zaghouani has spent the past 12 years in his lab at MU studying autoimmune diseases like type 1 diabetes.

Often called juvenile diabetes, the disease can lead to numerous complications, including cardiovascular disease, kidney damage, nerve damage, osteoporosis and blindness.

Type 1 diabetes attacks the pancreas. The organ, which is about the size of a hand and located in the abdomen, houses cell clusters called islets.

Islets contain beta cells that make insulin, which controls blood sugar levels. In people with type 1 diabetes, beta cells no longer make insulin because the body's immune system has attacked and destroyed them.

When the immune system strikes the beta cells, the attack causes collateral damage to capillaries that carry blood to and from the islets. The damage done to the tiny blood vessels led Zaghouani on a new path toward a cure.

In previous studies, Zaghouani and his team developed a drug against type 1 diabetes called Ig-GAD2. They found that treatment with the drug stopped the immune system from attacking beta cells, but too few beta cells survived the attack to reverse the disease.

In his latest study, Zaghouani used Ig-GAD2 and then injected adult stem cells from bone marrow into the pancreas in the hope that the stem cells would evolve into beta cells.

"The combination of Ig-GAD2 and bone marrow cells did result in production of new beta cells, but not in the way we expected," Zaghouani said. "We thought the bone marrow cells would evolve directly into beta cells. Instead, the bone marrow cells led to growth of new blood vessels, and it was the blood vessels that facilitated reproduction of new beta cells. In other words, we discovered that to cure type 1 diabetes, we need to repair the blood vessels that allow the subject's beta cells to grow and distribute insulin throughout the body."

Zaghouani is pursuing a patent for his promising treatment and hopes to translate his discovery from use in mice to humans. He is continuing his research with funding from the National Institutes of Health and MU.

"This is extremely exciting for our research team," he said. "Our discovery about the importance of restoring blood vessels has the potential to be applied not only to type 1 diabetes but also a number of other autoimmune diseases."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Unraveling the Elusive Structure of HIV Protein
Snapshots of HIV virus’ proteins may help design new ways to fight the disease.
Monday, July 06, 2015
MU Researchers Discover Protein's Ability To Inhibit HIV Release
TIM-family proteins have the ability to block the release of HIV and other viruses.
Wednesday, August 27, 2014
Scientific News
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
A Leap Forward in Vaccinating Against HIV
A team of scientists has developed an experimental vaccine candidate that successfully stimulates the immune system activity in animal models necessary to stop HIV infection.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!